A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) for Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy

Saved in:

Bibliographic Details
Published in	Clinical lymphoma, myeloma and leukemia Vol. 15; pp. S225 - S226
Main Authors	Rosenthal, Allison, Dueck, Amylou C., Ansell, Stephen M., Gano, Katherine, Conley, Christopher, Nowakowski, Grzegorz S., Curtis, Kelly, Camoriano, John, Leis, Jose F., Slack, James, Valdez, Riccardo, Mikhael, Joseph R., Stewart, A. Keith, Inwards, David, Dingli, David, Kumar, Shaji, Noel, Pierre, Gertz, Morie, Porrata, Luis, Russell, Stephen, Colgan, Joseph, Fonseca, Rafael, Habermann, Thomas M., Kapoor, Prashant, Buadi, Francis, Leung, Nelson, Tiedemann, Rodger, Witzig, Thomas E., Reeder, Craig
Format	Journal Article
Language	English
Published	Elsevier Inc 01.06.2015
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	2152-2650 2152-2669
DOI:	10.1016/j.clml.2015.04.104